Extendicare (TSE:EXE) Issues Earnings Results

Extendicare (TSE:EXE) issued its quarterly earnings data on Thursday. The company reported C$0.29 earnings per share (EPS) for the quarter, FiscalAI reports. The business had revenue of C$462.03 million for the quarter. Extendicare had a return on equity of 64.13% and a net margin of 4.48%.

Extendicare Price Performance

Shares of TSE:EXE opened at C$26.58 on Friday. The company’s fifty day moving average price is C$23.08 and its 200-day moving average price is C$18.73. The company has a debt-to-equity ratio of 283.02, a current ratio of 0.62 and a quick ratio of 0.98. The firm has a market capitalization of C$2.51 billion, a price-to-earnings ratio of 25.08 and a beta of 1.30. Extendicare has a one year low of C$11.80 and a one year high of C$27.08.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. BMO Capital Markets raised shares of Extendicare from a “hold” rating to an “outperform” rating and increased their price target for the stock from C$21.00 to C$24.00 in a report on Thursday, December 4th. Canadian Imperial Bank of Commerce increased their target price on shares of Extendicare from C$18.00 to C$22.00 in a research note on Thursday, November 13th. National Bank Financial raised their price target on shares of Extendicare from C$24.50 to C$29.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Royal Bank Of Canada upgraded shares of Extendicare from a “hold” rating to a “moderate buy” rating and boosted their price target for the company from C$15.00 to C$25.00 in a research report on Thursday, December 4th. Finally, Canaccord Genuity Group increased their price objective on Extendicare from C$20.00 to C$22.50 in a research report on Thursday, December 4th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of C$24.50.

Extendicare Company Profile

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.